New wound dressing aims to speed healing and fight infection
NCT ID NCT07576322
First seen May 13, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This study compares a new dressing called POLTX_Fiber to a standard one (Suprasorb Liquacel Pro) for chronic wounds like leg ulcers and pressure sores. About 60 adults with moderate-to-heavy wound drainage will be followed for 30 days. Researchers will track wound healing, infection signs, pain, and patient satisfaction using photos and assessments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC WOUND CARE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Geneva University Hospitals
Geneva, Canton of Geneva, 1205, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Instituions Hospital Du Nord Vaudois
Yverdon-les-Bains, Canton of Vaud, 1400, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lausanne University Hospital
Lausanne, Canton of Vaud, 1002, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
POLTX_Fiber dressing
What this could lead to
If it works, this could provide a better option for managing chronic wounds, potentially improving healing and reducing infection risk.
What could go wrong
This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The dressing is already approved, so major risks are low, but it may not outperform the standard dressing.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.